Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
January-2016 Volume 35 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2016 Volume 35 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Bergapten induces metabolic reprogramming in breast cancer cells

  • Authors:
    • Marta Santoro
    • Carmela Guido
    • Francesca De Amicis
    • Diego Sisci
    • Erika Cione
    • Vincenza Dolce
    • Ada Donà
    • Maria Luisa Panno
    • Saveria Aquila
  • View Affiliations / Copyright

    Affiliations: Centro Sanitario, University of Calabria, I-87030 Arcavacata di Rende (CS), Italy, Department of Pharmacy and Science of Health and Nutrition, University of Calabria, I-87030 Arcavacata di Rende (CS), Italy
  • Pages: 568-576
    |
    Published online on: October 8, 2015
       https://doi.org/10.3892/or.2015.4327
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Alterations in cellular metabolism are among the most consistent hallmarks of cancer. Herein, after a comprehensive metabolic phenotype characterization of MCF7 and ZR75 breast cancer cells, we investigated the activity of bergapten (Bg), a plant-derived compound, against breast cancer. The study of different biochemical pathways involved in cell metabolism revealed that the two cell lines have different bioenergetic phenotypes: MCF7 cells express a glycolytic phenotype only partially oxidative, while ZR75 cells mainly have an oxidative phenotype. In both cell lines, Bg blocked glycolysis and significantly decreased glucose-6-phosphate dehydrogenase (G6PDH) activity promoting glucose accumulation; modulated bioenergetic requirements altering the expression of oxidative phosphorylation (OXPHOS) complexes and ATP production; and induced a lipid-lowering effect since an increased lipase activity concomitantly to a reduction in triglyceride levels was observed. Quantitative data of different metabolites and enzymatic activities were presented. Treatment with Bg resulted in an alteration in different metabolic pathways inducing death in the cells. We report a novel action of the natural product Bg on breast cancer, since it induced metabolic reprogramming by disrupting the interconnected network of different metabolic mechanisms. Bg can be used in combination with other forms of targeted chemotherapy to improve cancer treatment outcomes.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Barger JF and Plas DR: Balancing biosynthesis and bioenergetics: Metabolic programs in oncogenesis. Endocr Relat Cancer. 17:R287–R304. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Smolková K, Plecitá-Hlavatá L, Bellance N, Benard G, Rossignol R and Ježek P: Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells. Int J Biochem Cell Biol. 43:950–968. 2011. View Article : Google Scholar

3 

Phan LM, Yeung S-C and Lee M-H: Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biol Med. 11:1–19. 2014.PubMed/NCBI

4 

Vamecq J, Colet JM, Vanden Eynde JJ, Briand G, Porchet N and Rocchi S: PPARs: Interference with Warburg' effect and clinical anticancer trials. PPAR Res. 2012:3047602012. View Article : Google Scholar : PubMed/NCBI

5 

Nabekura T: Overcoming multidrug resistance in human cancer cells by natural compounds. Toxins (Basel). 2:1207–1224. 2010. View Article : Google Scholar

6 

da Rocha AB, Lopes RM and Schwartsmann G: Natural products in anticancer therapy. Curr Opin Pharmacol. 1:364–369. 2001. View Article : Google Scholar : PubMed/NCBI

7 

Rowinsky EK: Paclitaxel pharmacology and other tumor types. Semin Oncol. 2:S19-1–S19-12. 1997.

8 

Jordan MA, Toso RJ, Thrower D and Wilson L: Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc Natl Acad Sci USA. 90:9552–9556. 1993. View Article : Google Scholar : PubMed/NCBI

9 

Moos PJ and Fitzpatrick FA: Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits. Cell Growth Differ. 9:687–697. 1998.PubMed/NCBI

10 

Huang Y, Johnson KR, Norris JS and Fan W: Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells. Cancer Res. 60:4426–4432. 2000.PubMed/NCBI

11 

McDaid HM and Horwitz SB: Selective potentiation of paclitaxel (Taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines. Mol Pharmacol. 60:290–301. 2001.PubMed/NCBI

12 

Panno ML, Giordano F, Mastroianni F, Palma MG, Bartella V, Carpino A, Aquila S and Andò S: Breast cancer cell survival signal is affected by bergapten combined with an ultraviolet irradiation. FEBS Lett. 584:2321–2326. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Panno ML, Giordano F, Palma MG, Bartella V, Rago V, Maggiolini M, Sisci D, Lanzino M, De Amicis F and Andò S: Evidence that bergapten, independently of its photoactivation, enhances p53 gene expression and induces apoptosis in human breast cancer cells. Curr Cancer Drug Targets. 9:469–481. 2009. View Article : Google Scholar : PubMed/NCBI

14 

Guido C, Panza S, Santoro M, Avena P, Panno ML, Perrotta I, Giordano F, Casaburi I, Catalano S, De Amicis F, et al: Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene. Cell Cycle. 11:2911–2921. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Saifer A and Gerstenfeld S: The photometric microdetermi-nation of blood glucose with glucose oxidase. J Lab Clin Med. 51:448–460. 1958.PubMed/NCBI

16 

Guido C, Perrotta I, Panza S, Middea E, Avena P, Santoro M, Marsico S, Imbrogno P, Andò S and Aquila S: Human sperm physiology: Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) influence sperm metabolism and may be involved in the pathophysiology of varicocele-associated male infertility. J Cell Physiol. 226:3403–3412. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Panteghini M, Bonora R and Pagani F: Measurement of pancreatic lipase activity in serum by a kinetic colorimetric assay using a new chromogenic substrate. Ann Clin Biochem. 38:365–370. 2001. View Article : Google Scholar : PubMed/NCBI

18 

Aquila S, Bonofiglio D, Gentile M, Middea E, Gabriele S, Belmonte M, Catalano S, Pellegrino M and Andò S: Peroxisome proliferator-activated receptor (PPAR)gamma is expressed by human spermatozoa: Its potential role on the sperm physiology. J Cell Physiol. 209:977–986. 2006. View Article : Google Scholar : PubMed/NCBI

19 

Pingitore A, Cione E, Senatore V and Genchi G: Adrenal glands and testes as steroidogenic tissue are affected by retinoylation reaction. J Bioenerg Biomembr. 41:215–221. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Gnoni GV and Paglialonga G: Resveratrol inhibits fatty acid and triacylglycerol synthesis in rat hepatocytes. Eur J Clin Invest. 39:211–218. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Luo J: Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett. 273:194–200. 2009. View Article : Google Scholar

22 

Zhang F and Du G: Dysregulated lipid metabolism in cancer. World J Biol Chem. 3:167–174. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Phan LM, Yeung SC and Lee MH: Cancer metabolic reprogramming: Importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biol Med. 11:1–19. 2014.PubMed/NCBI

24 

Mandal S and Davie JR: An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells. BMC Cancer. 7:1812007. View Article : Google Scholar : PubMed/NCBI

25 

Richardson AD, Yang C, Osterman A and Smith JW: Central carbon metabolism in the progression of mammary carcinoma. Breast Cancer Res Treat. 110:297–307. 2008. View Article : Google Scholar :

26 

Meadows AL, Kong B, Berdichevsky M, Roy S, Rosiva R, Blanch HW and Clark DS: Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells. Biotechnol Prog. 24:334–341. 2008. View Article : Google Scholar : PubMed/NCBI

27 

Tian WN, Braunstein LD, Pang J, Stuhlmeier KM, Xi QC, Tian X and Stanton RC: Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J Biol Chem. 273:10609–10617. 1998. View Article : Google Scholar : PubMed/NCBI

28 

Sun X, Wang JF, Tseng M and Young LT: Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci. 31:189–196. 2006.PubMed/NCBI

29 

Reinecke F, Smeitink JA and van der Westhuizen FH: OXPHOS gene expression and control in mitochondrial disorders. Biochim Biophys Acta. 1792:1113–1121. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Hardie DG: AMP-activated protein kinase: An energy sensor that regulates all aspects of cell function. Genes Dev. 25:1895–1908. 2011. View Article : Google Scholar : PubMed/NCBI

31 

Mihaylova MM and Shaw RJ: The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. 13:1016–1023. 2011. View Article : Google Scholar : PubMed/NCBI

32 

Shurbaji MS, Kalbfleisch JH and Thurmond TS: Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol. 27:917–921. 1996. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Santoro M, Guido C, De Amicis F, Sisci D, Cione E, Dolce V, Donà A, Panno ML and Aquila S: Bergapten induces metabolic reprogramming in breast cancer cells. Oncol Rep 35: 568-576, 2016.
APA
Santoro, M., Guido, C., De Amicis, F., Sisci, D., Cione, E., Dolce, V. ... Aquila, S. (2016). Bergapten induces metabolic reprogramming in breast cancer cells. Oncology Reports, 35, 568-576. https://doi.org/10.3892/or.2015.4327
MLA
Santoro, M., Guido, C., De Amicis, F., Sisci, D., Cione, E., Dolce, V., Donà, A., Panno, M. L., Aquila, S."Bergapten induces metabolic reprogramming in breast cancer cells". Oncology Reports 35.1 (2016): 568-576.
Chicago
Santoro, M., Guido, C., De Amicis, F., Sisci, D., Cione, E., Dolce, V., Donà, A., Panno, M. L., Aquila, S."Bergapten induces metabolic reprogramming in breast cancer cells". Oncology Reports 35, no. 1 (2016): 568-576. https://doi.org/10.3892/or.2015.4327
Copy and paste a formatted citation
x
Spandidos Publications style
Santoro M, Guido C, De Amicis F, Sisci D, Cione E, Dolce V, Donà A, Panno ML and Aquila S: Bergapten induces metabolic reprogramming in breast cancer cells. Oncol Rep 35: 568-576, 2016.
APA
Santoro, M., Guido, C., De Amicis, F., Sisci, D., Cione, E., Dolce, V. ... Aquila, S. (2016). Bergapten induces metabolic reprogramming in breast cancer cells. Oncology Reports, 35, 568-576. https://doi.org/10.3892/or.2015.4327
MLA
Santoro, M., Guido, C., De Amicis, F., Sisci, D., Cione, E., Dolce, V., Donà, A., Panno, M. L., Aquila, S."Bergapten induces metabolic reprogramming in breast cancer cells". Oncology Reports 35.1 (2016): 568-576.
Chicago
Santoro, M., Guido, C., De Amicis, F., Sisci, D., Cione, E., Dolce, V., Donà, A., Panno, M. L., Aquila, S."Bergapten induces metabolic reprogramming in breast cancer cells". Oncology Reports 35, no. 1 (2016): 568-576. https://doi.org/10.3892/or.2015.4327
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team